Sanofi pays $50 million for Revolution Medicines ’ SHP2 inhibitor

The partners expect to begin clinical studies of the compound later this year

Source: NanoFocus - July 18, 2018 Category: Nanotechnology Authors: Lisa Jarvis  Source Type: research